An observational study in Neuropathic Pain, Polyneuropathy and Peripheral Nerve Injury, sponsored by University of Kiel. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-01-28.
Sponsored by University of Kiel · Observational
Cross-sectional and longitudinal analysis of the somatosensory phenotype, assessed by quantitative sensory testing (QST) and Information obtained by questionnaires to detect risk factors for neuropathic pain development and chronification in painless and chronic pain patients.
1,287 studies on the registry are indexed under Neuralgia; 256 are open to participants now.
This study's planned enrollment of 1,500 is above the median of 100 across 260 observational studies indexed under Neuralgia.
Browse Neuralgia studies →University of Kiel is the lead sponsor of 25 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Painless patients and patients with chronic peripheral neuropathic pain.
Exclusion Criteria:
Patients with chronic peripheral neuropathic pain
Other: QST, Questionnaires
Painless patients before and after potential chronic neuropathic pain-inducing interventions (chemotherapy, Operation)
Other: QST, Questionnaires
Assessment of sensory phenotype by QST and questionnaires
Somatosensory phenotype detected by quantitative sensory testing (QST)
The somatosensory phenotype will be assessed by quantitative sensory testing (QST) once at baseline
Time frame: Single assessment at baseline (cross-sectional study). Report of complete cohort data at study completion
Change of neuropathic pain: Development and chronification of neuropathic pain detected by DN4 questionnaire
Assessment with DN4 pain questionnaire
Time frame: Assessment of change of neuropathic pain from baseline and 6 months after study enrollment (longitudinal study). Report of complete cohort data at study completion.
No study locations are listed for this record.
Plan to share: No
This study is status unknown, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Kiel